Dyadic International, Inc. (DYAI)
NASDAQ·Healthcare·Biotechnology
$0.33
-2.68%
Mkt Cap $28.95M
Analyst Ratings
No recent rating data.
Price Target (1 analysts)
$3.00
Range $3.00 – $3.00
Implied Upside
+806.3%
Consensus $3.00 vs current $0.33
NASDAQ·Healthcare·Biotechnology
$0.33
-2.68%
Mkt Cap $28.95M
No recent rating data.
Price Target (1 analysts)
$3.00
Range $3.00 – $3.00
+806.3%
Consensus $3.00 vs current $0.33